High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection

A 39-year-old woman with systemic lupus erythematosus treated with anti-CD20 monoclonal antibody rituximab was admitted to our hospital with COVID-19 pneumonia. Despite receiving dexamethasone, she developed hypoxaemia and persistent lung opacities. As bronchoalveolar lavage was suggestive of crypto...

Descripción completa

Detalles Bibliográficos
Autores principales: Moutinho-Pereira, Sara, Calisto, Raquel, Sabio, Federico, Guerreiro, Luísa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388267/
https://www.ncbi.nlm.nih.gov/pubmed/34433539
http://dx.doi.org/10.1136/bcr-2021-244853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388267/
https://www.ncbi.nlm.nih.gov/pubmed/34433539
http://dx.doi.org/10.1136/bcr-2021-244853

Ejemplares similares